MolNFT v1 · #127864 · protein
Crystal structure of unliganded human il-17RA
5N9B · Interleukin-17 receptor a: “Crystal structure of unliganded human il-17RA”. X-ray diffraction, 1 ligand (NAG), 1 pocket (best druggability 0.27). MolNFT v1 #127864 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 5N9B
- Type
- protein
- Length
- 244 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Interleukin-17 receptor a
- UniProt
- Q96F46
- Ligands
- NAG
- Pockets
- 1 · best druggability 0.27
Structure
x-ray diffraction · 1 distinct chain · 5% helix, 50% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Interleukin-17 receptor a | protein | 244 | 5% helix, 50% strand | Q96F46 |
Ligands and binding sites
- NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 4 copies · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 55 | 0.27 | 0.73 | 13 | empty |
Modifications
Observed in the structure: 6 disulfide, 4 glycan (disulfide, N-glycosylation).
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q96F46
- Elsewhere: RCSB PDB 5N9B · PDBe 5N9B · UniProt Q96F46
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.